Managed Care Cast-logo

Managed Care Cast

Health & Wellness Podcasts

Podcast by Managed Care Cast

Podcast by Managed Care Cast


United States


Podcast by Managed Care Cast




High-Deductible Health Plans and Their Potential Impact on the US Drug Epidemic

High-deductible health plans (HDHPs) have gained traction in recent years as a means to reduce unnecessary health care spending. The monthly premiums are low, but the high deductibles can lead to higher downstream costs for individuals and families. Potential downsides include the risk of patients deterring or avoiding necessary care. A team headed by Matthew D. Eisenberg, PhD, from the Johns Hopkins Bloomberg School of Public Health, recently investigated the impact of HDHPs through the...


The Importance of Tailored Care Management Programs for High-risk Patients

Teams from the Mass General Brigham health system and the Commonwealth Care Alliance, both in Massachusetts, have collaborated on a value-based care initiative with the principal goals of improving patient clinical outcomes, reducing unnecessary health care utilization, and making care more accessible. iCMP PLUS (Patients Linked to Urgent Support) is an integrated care management program providing intensive, multidisciplinary care to the highest-risk dual-eligible patients with Medicaid ACO...


Understanding the Premium Tax Credits Provided Under the American Rescue Plan Act

The Inflation Reduction Act, signed this month, extends the premium tax credits for health insurance purchased through the health care marketplace for another 2 years. The credits were included in the 2021 American Rescue Plan Act, and were due to expire at the end of this year. Vicki Fung, PhD, is associate investigator at the Mongan Institute Health Policy Center, Mass General Research Institute, and lead author of “Premium Tax Credits in the American Rescue Plan and Off-Marketplace...


How Health Care Institutions Can Leverage Biosimilars to Generate Savings

As more and more biosimilars enter different markets around the globe, payers and practices will need to consistently evaluate the economics of covering biosimilars and take a stance on whether to support their adoption. Both payers and practices can play a big role in encouraging biosimilar adoption, and health care institutions that have already begun pushing for more biosimilar use, such as Emory Healthcare, have seen substantial savings. On this episode of Managed Care Cast, we speak...


Reducing Health Care Disparities Starts at the Top, Says Dr Sachin Jain

Even before the pandemic began in 2020, the number of health care organizations appointing chief health equity officers had started to grow. Is this a role for 1 person only or do initiatives to tackle health care disparities and other issues begin at a higher level? And how can change really be accomplished so there is a measurable effect on health outcomes? In this episode of Managed Care Cast, we speak with Sachin Jain, MD, MBA, who joined SCAN Group and Health Plan 2 years ago as...


Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 2

Today we are bringing you part 2 of a 2-part sponsored podcast series discussing treatment goals in insterstitial lung disease (ILD). The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute. The conversation for today’s podcast includes an in-depth review of treatment landscape of systemic sclerosis ILD as well as a discussion on unmet needs and emerging therapies in ILD.


Improving the Mental Health of Children Through School-Based Prevention, Intervention Services

discusses why the program is needed, the goals of the program, and some of the reasons why children and adolescents are struggling. We also discuss 988, an upgrade to the National Suicide Prevention Lifeline number coming July 16, 2022. The number will connect individuals with trained counselors, and, if needed, send specially trained responders with the aim of reducing armed law enforcement interventions. If you or someone you know is in crisis, help is available by calling the the National...


Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1

Today we’re highlighting a discussion with a panel of experts in interstitial lung disease moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute. The topics of conversation for today’s podcast include treatment goals in patients with ILD and a review of treatment paradigms and standard of care therapies.


Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.


Generic Drug Savings Possibilities: $3.6 Billion to Medicare Using DTC Pricing

In January of this year, entrepreneur and Dallas Mavericks owner Mark Cuban launched a direct-to-consumer pharmacy called the Cost Plus Drug Company, promising savings by eliminating middlemen and charging cost plus 15% and a pharmacy fee. What if Medicare could do the same? On this episode of Managed Care Cast, we speak with a researcher who coauthored a study out this week that looked at the savings to Medicare Part D if the same model had been employed for some of the most used generic...


Biosimilar Whisky? This Expert Says It’s Doable, No Aging Required

On the After Hours section of Medical World News, we like to show you what scientists, researchers, health care providers, and others are doing in their spare time to relax and recharge. On this episode of Managed Care Cast, we’re highlighting a hobby from a biosimilar expert who says he can make whisky more accessible and affordable through—you guessed it—his own biosimilar whisky. Sarfaraz K. Niazi, PhD, is an adjunct professor of biopharmaceutical sciences at the University of Illinois...


Excess COVID-19 Deaths in Republican Counties Paints Voting as a Proxy for Public Health Support

The pandemic highlighted deep partisan divisions in the United States over public health measures. Disputes over masking and beliefs about science and vaccines that prevent severe illness and death from infection with SARS-CoV2, the virus that causes COVID-19, affected nearly every area of life. That rancor impacted death rates in counties that voted Republican in the 2020 presidential election, according to a new study out Monday in the journal Health Affairs. In counties where 70% or more...


Assessing the Association Between Income Inequality and Health

Income inequality is a hot topic in politics today, and while the rising role of social determinants of health is being recognized in care delivery and research, a new study published in Social Science & Medicine aimed to determine to what extent income gaps are associated with Americans’ declining health. On this episode of Managed Care Cast, we speak with Hui Zheng, PhD, an associate professor in the Department of Sociology at Ohio State University and co-author of “Rising Childhood Income...


Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer

Cholangiocarcinoma—or biliary duct cancer—affects about 8000 US patients a year. On this episode of Managed Care Cast, we bring you an excerpt of an interview with Jesper B. Andersen, PhD, associate professor and group leader at the University of Copenhagen and the Biotech Research and Innovation center at the Department of Health. There have been 3 FDA drug approvals for drugs that treat cholangiocarcinoma, but only for patients that have certain mutations or rearrangements, signifying an...


Understanding Opioid Use Among Patients With Cancer

On this episode of Managed Care Cast, we speak with Tham Le, PhD, MPH, and Linda Wastila, PhD, MSPH, lead and senior authors, respectively, of “Patterns of Opioid Use in Commercially Insured Patients With Cancer,” which was published in the May issue of The American Journal of Managed Care®. They took up their investigation after finding that most previous similar studies of opioid use focused on problems with opioid use among general populations and that patients with cancer are an often...


Trends Show Uptake of SUD Treatment Has Room for Improvement

Drug overdose deaths are skyrocketing, with more than 100,000 people dying in 2021, according to the CDC. Obtaining treatment for substance use disorders (SUDs) has never been easy, and this month in Health Affairs, a recent paper examined trends in the use of treatment services to see what, if anything, changed from 2010 to 2019. Despite an increase in insurance coverage over much of that time period and other policy changes, the results were disappointing, according to one of the authors...


For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management

On this episode of Managed Care Cast, we speak with Dr Joanne Armstrong, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women, applicability of current screening and care delivery guidelines for heart health in regards to minority populations, and how her own health experiences have influenced her perspective on cardiovascular disease management.


Major Study Expands in Hopes to Cure Parkinson Disease

April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people. The study is investigating the biomarkers and other data collected from a wide range of individuals—those...


Exploring Payer Coverage Decisions Following FDA Novel Drug Approvals

In 2018, the FDA approved a record 66 novel drugs. Among them were cancer treatments, orphan drugs for rare diseases, drugs under expedited review, and biosimilars. However, access to each of these drugs for patients covered by different health plans was not uniform. On this episode of Managed Care Cast, we speak with Ari D. Panzer, BS, a master of public policy candidate at Duke University, and lead author of “Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval,” which was...


Advocating for All Patients With Chronic Kidney Disease

Entering its 51st year, the American Kidney Fund has made it its mission to help all patients affected by chronic kidney disease (CKD), which is the fastest-growing noncontagious disease in the United States: from those at risk for chronic kidney disease through patients requiring dialysis and/or transplant. First and foremost is uncovering the primary cause of their kidney failure. Unfortunately, for 14% of low-income patients, the origins of their CKD remain a medical mystery. In December...